GAM
RMD icon

Generali Asset Management’s ResMed RMD Stock Holding History

Generali Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$637K Sell
3,270
-5,921
-64% -$1.23M 0.01% 382
2026
Q1 		$2.06M Buy
9,191
+2,357
+34% +$587K 0.04% 289
2025
Q4 		$1.65M Sell
6,834
-2,412
-26% -$617K 0.03% 341
2025
Q3 		$2.53M Sell
9,246
-769
-8% -$210K 0.05% 258
2025
Q2 		$2.58M Sell
10,015
-2,680
-21% -$639K 0.06% 261
2025
Q1 		$2.84M Sell
12,695
-5,653
-31% -$1.32M 0.07% 249
2024
Q4 		$4.2M Buy
+18,348
New +$4.42M 0.11% 184

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Generali Asset Management's RMD Position: Q2 2026 in Review

Generali Asset Management reduced its ResMed (RMD) stake by 64% in Q2 2026, selling an estimated $1.23M and leaving 3,270 shares worth $637K. The position accounts for 0.01% of the portfolio, ranked #382.

Generali Asset Management first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.2M in Q4 2024. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Generali Asset Management held 3,270 shares of ResMed worth $637K as of Q2 2026.
  • Generali Asset Management sold 5,921 ResMed shares in Q2 2026, an estimated $1.23M.
  • ResMed made up 0.01% of Generali Asset Management's portfolio in Q2 2026, its #382 holding.
  • Generali Asset Management first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's ResMed position peaked at $4.2M in Q4 2024.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.